← Leaderboards
Craig T Cheetham
Kaiser Foundation Research Institute
$227,630
Attributed
$455,259
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $236.4K · FY2012–13$250K$187.5K$125K$62.5K$0
'12
'13
Funding mix
By agency
NIH$455,259 · 1
By mechanism
R01$455,259 · 1
Top collaborators
- Stephen K. Van Den Eeden3 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Stephen K. Van Den Eeden$13,042,835
- Marvin Epolian Langston$1,509,245
- John Hsu$21,513,960
- Bobbijo H. Yarborough$6,037,581
- Gregory E Simon$47,932,393
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsAffectAftercareAgingAmbulatory CareAndrogensBenefits And RisksBenignBenign Prostatic HypertrophyCardiovascular DiseasesCardiovascular Risk FactorCardiovascular SystemClinical DataCohortCohort AnalysisCohort StudiesComorbidityComplexDatabasesDecreased LibidoDiagnosisDiagnostic TestsDrug FormulationsAccounting
Grant awards (3)
Cardiovascular and Prostatic Safety of Testosterone Therapy in Aging Males$203,040
R01 · FY2013 · AG · contact PI
Cardiovascular and Prostatic Safety of Testosterone Therapy in Aging Males$33,380
R01 · FY2013 · AG · contact PI
Cardiovascular and Prostatic Safety of Testosterone Therapy in Aging Males$218,839
R01 · FY2012 · AG · contact PI